Previous close | 217.45 |
Open | 214.87 |
Bid | 216.04 x 900 |
Ask | 222.44 x 1100 |
Day's range | 214.87 - 218.66 |
52-week range | 174.60 - 234.30 |
Volume | |
Avg. volume | 5,881,830 |
Market cap | 456.908B |
Beta (5Y monthly) | 0.96 |
PE ratio (TTM) | 44.93 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.80 (0.78%) |
Ex-dividend date | 09 Feb 2023 |
1y target est | N/A |
S&P Dow Jones and MSCI will reclassify the Global Industry Classification Standard structure after the close on 17 March. These sector ETFs will be impacted.
There is nothing like a bear market to emphasize the importance of investing in solid, reliable, and steady companies that can deliver consistent revenue and earnings for a long time. Two such companies are AstraZeneca (NASDAQ: AZN) and Visa (NYSE: V). U.K.-based AstraZeneca is a drugmaker with a vast, diversified portfolio of over three-dozen products across six major segments.
These three stocks have had average annual earnings growth of more than 15% during the past five years.